13May 2023
Utility of modified Glasgow prognostic score for head and neck squamous cell carcinoma: Systematic review and meta‐analysis

Utility of modified Glasgow prognostic score for head and neck squamous cell carcinoma: Systematic review and meta‐analysis

A systematic review and meta-analysis evaluated the usefulness of the modified Glasgow prognostic score (mGPS) in patients with head and neck squamous cell carcinoma (HNSCC). The analysis included 11 studies with a total of 2017 HNSCC patients. The results showed that a higher mGPS was associated with poorer progression-free survival, overall survival, disease-specific survival, and disease-free survival in HNSCC patients. The findings suggest that the mGPS can serve as a valid prognostic biomarker for individuals diagnosed with HNSCC. The study supports the potential clinical utility of the mGPS in predicting outcomes in HNSCC patients.

  • #ent

Like

Save

Share